Chief Medical Officer · Innoviva, Inc. (INVA)

Margaret Koziel

FY2023 is the first fiscal year CompBrief holds for Margaret Koziel as a named executive officer of Innoviva; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2023

$967,680

Salary $187,500Stock awards $0Bonus $300,000

3rd of 5 named executive officers at Innoviva by FY2023 total.

5 named officers on file for Innoviva, FY2023

Margaret Koziel’s pay file — $29

  • 1 fiscal year of pay, line by line
  • 1 equity grant, each cited to its filing
  • INVA’s disclosed peer group of 17 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Innoviva’s whole pay program stands against its peers

  • Innoviva’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on INVA→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 29, 2024 (DEF 14A).

Free

Get Margaret Koziel’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Margaret Koziel compensation by year

Innoviva Summary Compensation Table · the one fiscal year held
In US dollars, as Innoviva reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2023
Salary$187,500
Bonus$300,000
Stock awards$0
Option awards$356,430
Non-equity incentive$0
Pension and deferred compensation$0
All other$123,750
Total$967,680

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Innoviva, Inc. DEF 14A filed April 29, 2024, accession 0001193125-24-122923, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Innoviva, Inc. filed document, accession 0001193125-24-122923. Every figure is read from that document and cited to the page and table it appears in. Filed April 29, 2024.

Innoviva’s named executive officers, FY2023

as the company reported each
Named executive officerRoleFY2023 total
Larry EdwardsPresident$1,426,182
Stephen BassoChief Financial Officer$1,182,051
Margaret Koziel · this pageChief Medical Officer$967,680
Marianne ZhenChief Accounting Officer$924,209
Pavel RaifeldChief Executive Officer$868,648

The full Innoviva compensation record

free company brief

This page is one person within Innoviva's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Innoviva proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Innoviva's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Margaret Koziel's compensation dossier · One-time report. No refunds.